Global Pharma Companies Must Nurture ‘Intercultural Intelligence’
Insights From Jesse Sibarium, SVP, General Manager At PTC Therapeutics
Generate a summary of this article
Listen to this article
Equality, Diversity and Inclusion (ED&I) carries huge potential for business and society. However, various events around the globe, including the Black Lives Matter movement, highlighted that there are unaddressed challenges which need to be tackled. PTC Therapeutics, a global biopharmaceutical company with presence in in Europe, Middle East and Africa (EMEA) has initiated a new ED&I program to further strengthen its values and encourage positive progress globally.
• Source: Shutterstock
PTC Therapeutics, Inc. has been operating across more than 20 EMEA countries, arguably one of the most culturally diverse regions with over 2,000 languages spoken and every world religion represented, for nearly 10 years.
About the Author
Jesse Sibarium is senior vice president, general manager for Central Eastern Europe, Commonwealth of Independent States, Middle East and Africa at PTC Therapeutics.
PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of medicines that provide benefits to patients with rare disorders.
Candid conversations with C-suite leaders.
Keep up with strategy, innovation and evolving trends across life science industries.
Although pharmaceuticals are exempt from the US reciprocal tariff policy, for now, the escalating global trade war is already posing practical on-the-ground problems for some companies, In Vivo investigates.
The E in ESG: SUDs, reuse, disposables, refurbishing, reprocessed devices? Multiple panelists at the 2024 MedTech Forum addressed the role medtech manufacturers should have in the climate change challenge.
Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.
Leadership succession is proceeding within South Korean pharmaceutical corporations such as Daiichi Sankyo Korea, Astellas Pharma Korea, Kyowa Kirin Korea as well as MSD Korea.
The E in ESG: SUDs, reuse, disposables, refurbishing, reprocessed devices? Multiple panelists at the 2024 MedTech Forum addressed the role medtech manufacturers should have in the climate change challenge.
Stefan Woxström, senior vice president of AstraZeneca, Europe and Canada, discusses the growing challenges in the industry and addresses the role big pharma must adopt in resolving them.
Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.
